MACCARONI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 2.959
EU - Europa 1.351
AS - Asia 1.027
SA - Sud America 191
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.620
Nazione #
US - Stati Uniti d'America 2.916
IT - Italia 339
SG - Singapore 327
CN - Cina 235
RU - Federazione Russa 177
VN - Vietnam 168
UA - Ucraina 157
BR - Brasile 149
DE - Germania 126
SE - Svezia 112
IE - Irlanda 97
HK - Hong Kong 74
TR - Turchia 71
FR - Francia 64
FI - Finlandia 63
DK - Danimarca 61
GB - Regno Unito 58
CI - Costa d'Avorio 39
IN - India 34
KR - Corea 32
BD - Bangladesh 30
PL - Polonia 26
CA - Canada 22
MA - Marocco 22
NL - Olanda 17
AR - Argentina 16
JP - Giappone 14
MX - Messico 14
ZA - Sudafrica 14
BE - Belgio 11
ES - Italia 11
EC - Ecuador 8
CO - Colombia 6
AT - Austria 5
CZ - Repubblica Ceca 5
PH - Filippine 5
PK - Pakistan 5
IQ - Iraq 4
RO - Romania 4
CL - Cile 3
DZ - Algeria 3
ID - Indonesia 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
SA - Arabia Saudita 3
SC - Seychelles 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PT - Portogallo 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 5.620
Città #
Ashburn 523
Chandler 262
Singapore 207
San Jose 186
Jacksonville 169
Fairfield 166
Dallas 123
Dublin 97
New York 94
Boardman 90
Wilmington 86
Ann Arbor 79
Woodbridge 74
Hong Kong 70
Beijing 69
Centro 69
Houston 66
Seattle 62
Los Angeles 60
Cambridge 55
Council Bluffs 55
Hanoi 52
Ho Chi Minh City 50
Moscow 47
Munich 42
Des Moines 40
Abidjan 39
Lawrence 37
Princeton 37
San Mateo 35
The Dalles 33
Lauterbourg 32
Turin 30
Orem 25
Turku 25
Warsaw 25
Milan 24
Chicago 23
Ancona 19
Rome 19
Buffalo 18
Hefei 15
San Diego 15
Santa Clara 15
Helsinki 12
London 12
Tokyo 12
Johannesburg 11
Atlanta 10
Brussels 10
Pune 10
São Paulo 10
Brooklyn 9
Montreal 9
Amsterdam 8
Miano 8
Poplar 8
Salt Lake City 8
Chennai 7
Da Nang 7
Washington 7
Cagliari 6
Canicattì 6
Elk Grove Village 6
Florence 6
Manchester 6
Mexico City 6
Rio de Janeiro 6
Stockholm 6
Boston 5
Denver 5
Falconara Marittima 5
Guangzhou 5
Jiaxing 5
Marche 5
New Delhi 5
Olomouc 5
Paris 5
Phoenix 5
Tampa 5
Wuxi 5
Bari 4
Brasília 4
Columbus 4
Curitiba 4
Frankfurt am Main 4
Haiphong 4
Modena 4
Mumbai 4
New Bedfont 4
Shanghai 4
Sterling 4
Thái Nguyên 4
Vienna 4
Wuhan 4
Amman 3
Belo Horizonte 3
Birmingham 3
Biên Hòa 3
City of London 3
Totale 3.696
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 222
Caratterizzazione istologica e molecolare nelle pazienti con carcinoma ovarico sporadico ed ereditario 204
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 195
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 194
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 191
Optimal management of resected gastric cancer 188
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. 183
5-Fluorouracil pharmacogenomics: still rocking after all these years? 175
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 173
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 171
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy. 168
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 168
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 168
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 163
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 161
Adjuvant treatment after surgical resection 156
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal? 147
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 146
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 144
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 142
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 142
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 142
Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2. 141
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 140
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 135
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 133
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 133
New Insights into Hormonal Therapies in Uterine Sarcomas 133
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 130
Transient sunitinib resistance in gastrointestinal stromal tumors. 128
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 125
Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1. 112
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 111
Locally advanced rectal cancer: new findings in anticancer therapy 109
Thymic epithelial tumors (TETs) and additional tumors: a single Centre experience 104
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 100
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 86
Totale 5.701
Categoria #
all - tutte 25.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022315 25 77 9 5 1 15 16 22 16 42 21 66
2022/2023714 52 96 51 55 52 103 1 47 150 6 86 15
2023/2024392 59 10 26 46 54 108 4 13 1 8 7 56
2024/2025738 104 58 14 14 46 24 86 31 110 53 108 90
2025/20262.217 205 129 136 227 312 159 344 195 166 182 61 101
2026/202748 48 0 0 0 0 0 0 0 0 0 0 0
Totale 5.701